The University of Chicago Header Logo

Peter Sand

Concepts (518)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder, Overactive
39
2021
87
9.130
Why?
Urinary Incontinence, Stress
53
2023
192
7.960
Why?
Urinary Incontinence
53
2020
206
6.730
Why?
Muscarinic Antagonists
25
2012
55
5.420
Why?
Mandelic Acids
20
2013
20
3.870
Why?
Vagina
18
2022
161
3.660
Why?
Uterine Prolapse
15
2022
77
3.240
Why?
Cystitis, Interstitial
12
2023
53
2.830
Why?
Pelvic Floor
19
2022
84
2.740
Why?
Urethra
21
2023
113
2.600
Why?
Urinary Incontinence, Urge
11
2021
42
2.520
Why?
Urinary Bladder Diseases
13
2012
41
2.430
Why?
Pelvic Organ Prolapse
9
2022
139
2.380
Why?
Quality of Life
29
2021
1585
2.310
Why?
Surgical Mesh
10
2022
116
2.310
Why?
Urodynamics
36
2023
122
2.260
Why?
Wound Healing
7
2012
344
2.060
Why?
Benzhydryl Compounds
11
2012
48
2.010
Why?
Electric Stimulation Therapy
13
2021
51
2.000
Why?
Female
192
2023
44550
1.940
Why?
Nortropanes
9
2011
10
1.900
Why?
Surveys and Questionnaires
25
2020
2504
1.850
Why?
Urologic Surgical Procedures
11
2018
146
1.790
Why?
Gynecologic Surgical Procedures
9
2019
135
1.720
Why?
Treatment Outcome
64
2023
7998
1.520
Why?
Middle Aged
118
2021
25040
1.500
Why?
Urinary Bladder
22
2023
246
1.500
Why?
Aged
99
2020
18423
1.470
Why?
Humans
203
2023
86678
1.380
Why?
Delivery, Obstetric
10
2018
112
1.340
Why?
Fecal Incontinence
8
2014
57
1.230
Why?
Patient Satisfaction
8
2018
455
1.210
Why?
Urology
11
2016
110
1.140
Why?
Skin
4
2012
554
1.110
Why?
Terminology as Topic
10
2011
217
1.110
Why?
Prostheses and Implants
8
2011
121
1.030
Why?
Nocturia
4
2023
19
1.030
Why?
Transcutaneous Electric Nerve Stimulation
3
2019
12
1.020
Why?
Suburethral Slings
6
2018
73
1.000
Why?
Pentosan Sulfuric Polyester
5
2008
7
0.980
Why?
Dimethyl Sulfoxide
5
2023
38
0.960
Why?
Cresols
9
2009
17
0.950
Why?
Ligaments
4
2017
32
0.920
Why?
Phenylpropanolamine
8
2009
15
0.910
Why?
Botulinum Toxins, Type A
7
2018
49
0.880
Why?
Menopause
3
2012
71
0.860
Why?
Skin Transplantation
2
2020
172
0.860
Why?
Transforming Growth Factor beta1
2
2012
87
0.840
Why?
Implantable Neurostimulators
1
2021
12
0.800
Why?
Pelvic Floor Disorders
4
2014
55
0.800
Why?
Parasympatholytics
3
2009
18
0.800
Why?
Adult
76
2019
25659
0.790
Why?
Double-Blind Method
24
2013
1824
0.790
Why?
Sexuality
2
2014
40
0.780
Why?
Aged, 80 and over
36
2018
6513
0.780
Why?
Urologic Diseases
5
2013
45
0.770
Why?
Cystoscopy
7
2008
35
0.750
Why?
Pregnancy, Multiple
3
2005
37
0.730
Why?
Collagen
5
2007
269
0.720
Why?
Urination Disorders
7
2004
50
0.710
Why?
Postoperative Complications
14
2011
2207
0.680
Why?
Suture Techniques
4
2017
135
0.680
Why?
Prospective Studies
28
2023
4214
0.680
Why?
Diabetes Mellitus, Type 1
3
2014
568
0.680
Why?
Counseling
2
2018
145
0.650
Why?
Urinary Catheterization
4
2004
35
0.640
Why?
Follow-Up Studies
22
2019
3642
0.640
Why?
Pregnancy Complications
3
2018
336
0.640
Why?
Triamcinolone
3
2023
18
0.640
Why?
Tibial Nerve
5
2021
14
0.630
Why?
Pelvic Pain
4
2008
80
0.620
Why?
Retrospective Studies
26
2018
8496
0.610
Why?
Rabbits
7
2012
636
0.610
Why?
Ovariectomy
3
2012
81
0.590
Why?
Pain, Postoperative
2
2017
240
0.570
Why?
Cholinergic Antagonists
6
2019
26
0.570
Why?
Anti-Inflammatory Agents
4
2017
339
0.560
Why?
Cesarean Section
5
2018
137
0.550
Why?
Women's Health
4
2010
100
0.550
Why?
Colpotomy
2
2012
4
0.530
Why?
Benzilates
9
2011
9
0.530
Why?
Recurrence
12
2020
1139
0.520
Why?
Urethral Diseases
3
2006
15
0.520
Why?
International Cooperation
6
2010
127
0.520
Why?
Neuromuscular Agents
4
2016
25
0.520
Why?
Magnetics
4
2003
41
0.510
Why?
Administration, Cutaneous
9
2013
58
0.510
Why?
Communication
1
2018
442
0.500
Why?
Pregnancy
17
2023
2894
0.490
Why?
Male
49
2021
40988
0.490
Why?
Tetrahydroisoquinolines
3
2009
4
0.490
Why?
Pain
4
2023
391
0.480
Why?
Durapatite
2
2011
28
0.480
Why?
Vesico-Ureteral Reflux
1
2014
28
0.480
Why?
Quinuclidines
3
2009
26
0.480
Why?
Delayed-Action Preparations
11
2011
116
0.470
Why?
Rectocele
2
2005
7
0.460
Why?
Models, Economic
1
2013
60
0.460
Why?
Antidiuretic Agents
1
2013
3
0.460
Why?
Female Urogenital Diseases
2
2010
9
0.460
Why?
Time Factors
15
2021
5214
0.450
Why?
Deamino Arginine Vasopressin
1
2013
12
0.450
Why?
Uterus
1
2014
215
0.450
Why?
Symptom Assessment
1
2013
65
0.450
Why?
Safety
2
2012
152
0.440
Why?
Severity of Illness Index
11
2013
1802
0.440
Why?
Lower Urinary Tract Symptoms
1
2013
59
0.440
Why?
Family Health
1
2013
162
0.440
Why?
Cohort Studies
12
2018
2768
0.430
Why?
Sutures
2
2011
52
0.430
Why?
Proto-Oncogene Proteins c-sis
1
2012
27
0.430
Why?
Societies, Medical
4
2010
573
0.430
Why?
Cross-Sectional Studies
7
2023
1621
0.420
Why?
Drug Administration Schedule
12
2013
916
0.410
Why?
Granuloma, Foreign-Body
1
2011
6
0.410
Why?
Syringes
2
2002
13
0.400
Why?
Gynecology
4
2016
124
0.390
Why?
Rectal Fistula
1
2011
18
0.390
Why?
Multiple Sclerosis
1
2013
262
0.390
Why?
Pressure
8
2006
165
0.390
Why?
Disease Management
1
2013
327
0.390
Why?
Multivariate Analysis
8
2013
1001
0.380
Why?
Pelvis
3
2005
95
0.380
Why?
Reoperation
6
2020
597
0.380
Why?
Dose-Response Relationship, Drug
8
2013
1961
0.360
Why?
Tartrates
3
2004
6
0.360
Why?
Biocompatible Materials
1
2011
193
0.360
Why?
Adolescent
22
2021
8984
0.360
Why?
Abdomen
4
2007
122
0.350
Why?
Dermis
2
2009
27
0.350
Why?
Administration, Intravesical
5
2023
33
0.350
Why?
Craniosynostoses
2
2021
77
0.350
Why?
Urinary Retention
3
2016
40
0.340
Why?
Self Report
2
2021
288
0.340
Why?
Tolterodine Tartrate
8
2009
15
0.340
Why?
Work
1
2009
16
0.340
Why?
Recovery of Function
1
2010
272
0.340
Why?
Efficiency
1
2009
40
0.330
Why?
Estrogens
3
2023
200
0.330
Why?
Developmental Disabilities
2
2021
195
0.320
Why?
Analgesics, Non-Narcotic
1
2008
46
0.320
Why?
Narcotics
1
2008
69
0.310
Why?
Probability
8
2008
355
0.310
Why?
Twins, Monozygotic
4
2010
57
0.310
Why?
Granulation Tissue
1
2007
15
0.300
Why?
Risk Assessment
10
2019
2264
0.290
Why?
Surgical Tape
1
2006
4
0.290
Why?
Injections
2
2005
109
0.290
Why?
Urological Agents
2
2018
5
0.290
Why?
Wounds, Penetrating
1
2007
47
0.290
Why?
Constipation
5
2010
63
0.280
Why?
Hematuria
3
2008
49
0.280
Why?
Carcinoma, Transitional Cell
1
2008
164
0.280
Why?
Risk Factors
12
2013
5420
0.270
Why?
Medication Adherence
2
2018
129
0.270
Why?
Reproducibility of Results
7
2013
2706
0.270
Why?
Age Factors
8
2012
1852
0.270
Why?
Postoperative Care
2
2004
221
0.270
Why?
Fascia Lata
1
2005
7
0.270
Why?
Intrauterine Devices
1
2005
28
0.260
Why?
Dehydration
1
2005
18
0.260
Why?
Gels
5
2013
48
0.260
Why?
Logistic Models
6
2008
1188
0.260
Why?
Colposcopy
1
2005
14
0.260
Why?
Dyspareunia
1
2005
19
0.260
Why?
Solvents
1
2005
96
0.260
Why?
Sweden
3
2014
40
0.250
Why?
Psychometrics
5
2014
327
0.250
Why?
Surgical Procedures, Operative
1
2007
182
0.250
Why?
Cystitis
1
2004
13
0.250
Why?
Equipment Design
2
2021
407
0.250
Why?
Urinary Tract Infections
3
2021
76
0.240
Why?
Elective Surgical Procedures
1
2005
116
0.240
Why?
Anal Canal
3
2011
89
0.240
Why?
Sexual Dysfunction, Physiological
3
2013
67
0.240
Why?
Urinary Bladder Neoplasms
1
2008
383
0.240
Why?
Transplantation, Heterologous
1
2005
363
0.240
Why?
Eosinophilia
1
2004
84
0.240
Why?
Exercise Therapy
2
2002
80
0.230
Why?
Delivery of Health Care
1
2008
426
0.230
Why?
Urination
5
2012
37
0.230
Why?
Puerperal Disorders
1
2003
32
0.230
Why?
Prevalence
4
2014
1239
0.230
Why?
Muscle Contraction
4
2014
284
0.220
Why?
Administration, Oral
6
2013
684
0.220
Why?
Parity
5
2011
93
0.220
Why?
Allografts
2
2020
172
0.220
Why?
Bupivacaine
3
2023
45
0.220
Why?
Feasibility Studies
3
2021
751
0.220
Why?
Random Allocation
3
2012
332
0.220
Why?
Reference Values
7
2013
674
0.210
Why?
Mothers
1
2003
141
0.210
Why?
Predictive Value of Tests
10
2012
1673
0.200
Why?
Polyglactin 910
1
2001
5
0.200
Why?
Prosthesis Implantation
2
2021
125
0.200
Why?
Trimethoprim
1
2021
15
0.200
Why?
Adaptation, Psychological
2
2021
157
0.200
Why?
Urogenital Surgical Procedures
2
2011
10
0.200
Why?
Drug Therapy, Combination
4
2017
895
0.200
Why?
Glutaral
1
2000
5
0.190
Why?
Heparin
2
2023
175
0.190
Why?
Animals
9
2012
26590
0.190
Why?
Carcinoma, Squamous Cell
1
2008
1077
0.190
Why?
Transplants
2
2011
40
0.190
Why?
Diffusion of Innovation
1
2001
71
0.190
Why?
Epidemiologic Methods
2
2010
59
0.190
Why?
Acetylcholine Release Inhibitors
2
2016
3
0.180
Why?
Evidence-Based Medicine
6
2011
429
0.180
Why?
Electric Stimulation
1
2000
347
0.180
Why?
Incidence
6
2019
1578
0.180
Why?
Minimally Invasive Surgical Procedures
3
2014
237
0.180
Why?
Solifenacin Succinate
3
2009
6
0.170
Why?
Urinary Sphincter, Artificial
1
1999
13
0.170
Why?
Condylomata Acuminata
3
1987
15
0.170
Why?
Randomized Controlled Trials as Topic
4
2011
865
0.170
Why?
Urinary Tract
2
2013
34
0.170
Why?
Cryosurgery
2
1989
41
0.160
Why?
Syndrome
3
2019
446
0.160
Why?
Electrodes, Implanted
1
2019
171
0.160
Why?
Pubic Bone
3
2004
9
0.160
Why?
Parturition
1
2018
21
0.160
Why?
Secondary Prevention
3
2005
162
0.160
Why?
Chronic Disease
5
2010
973
0.160
Why?
Observational Studies as Topic
1
2018
48
0.160
Why?
Sacrococcygeal Region
1
2017
9
0.150
Why?
Health Knowledge, Attitudes, Practice
2
2016
508
0.150
Why?
Orthopedic Procedures
1
2019
128
0.150
Why?
Pain Measurement
2
2017
321
0.150
Why?
Hernia, Ventral
1
1997
24
0.150
Why?
Cystostomy
1
1997
15
0.150
Why?
Hysterectomy
2
2008
146
0.150
Why?
Vulvar Diseases
2
2008
8
0.150
Why?
Odds Ratio
5
2008
680
0.140
Why?
Case-Control Studies
3
2018
1807
0.140
Why?
Clinical Trials as Topic
2
2013
1169
0.140
Why?
Ultrasonography
3
2018
695
0.140
Why?
Illinois
1
2017
462
0.140
Why?
Lumbosacral Plexus
2
2005
9
0.140
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
1998
243
0.140
Why?
Child
5
2021
6928
0.130
Why?
Combined Modality Therapy
2
2010
1686
0.130
Why?
Cystocele
2
2019
7
0.130
Why?
Postoperative Period
3
2006
303
0.130
Why?
Young Adult
8
2018
5980
0.130
Why?
Xerostomia
3
2004
10
0.130
Why?
Prolapse
2
2005
10
0.130
Why?
Anatomic Landmarks
1
2014
31
0.130
Why?
Diagnosis, Differential
2
2010
1566
0.130
Why?
Compliance
1
2014
23
0.120
Why?
Urinary Bladder, Neurogenic
2
2001
25
0.120
Why?
Longitudinal Studies
1
2018
1019
0.120
Why?
Analysis of Variance
4
2004
912
0.120
Why?
Physician-Patient Relations
2
2018
610
0.120
Why?
Surgeons
1
2018
238
0.120
Why?
Muscles
2
1991
194
0.120
Why?
Diagnostic Techniques, Urological
1
2013
13
0.120
Why?
Medication Therapy Management
1
2013
16
0.120
Why?
Patient Safety
2
2013
212
0.110
Why?
Diabetes Complications
1
2014
207
0.110
Why?
Drug Administration Routes
1
2012
19
0.110
Why?
Patient Compliance
2
2012
228
0.110
Why?
Internal Medicine
1
2016
349
0.110
Why?
Evaluation Studies as Topic
3
2007
274
0.110
Why?
Sex Factors
2
2012
1055
0.110
Why?
Confidence Intervals
3
2004
229
0.110
Why?
United States
9
2012
6681
0.100
Why?
Osteomyelitis
2
2004
54
0.100
Why?
Biofeedback, Psychology
2
2007
12
0.100
Why?
Health Status Indicators
1
2012
105
0.100
Why?
Equipment Reuse
2
2002
6
0.100
Why?
Medical History Taking
2
2008
80
0.100
Why?
Age Distribution
1
2012
204
0.100
Why?
Injections, Intramuscular
3
2016
62
0.100
Why?
Internship and Residency
1
2001
1010
0.100
Why?
Real-Time Polymerase Chain Reaction
1
2012
273
0.100
Why?
Prosthesis Failure
1
2011
111
0.100
Why?
Cognition
3
2021
571
0.100
Why?
Electromagnetic Phenomena
2
2001
18
0.100
Why?
Perineum
1
2011
35
0.100
Why?
Diverticulum
1
2011
44
0.100
Why?
Cost Savings
2
2002
67
0.100
Why?
Risk
4
2006
674
0.100
Why?
Polytetrafluoroethylene
1
2011
74
0.100
Why?
Magnetic Resonance Imaging
2
2018
3362
0.100
Why?
Depression
1
2014
473
0.100
Why?
Abscess
1
2011
91
0.090
Why?
Placebos
1
2011
218
0.090
Why?
Vancomycin
1
2011
72
0.090
Why?
Rectum
2
2010
146
0.090
Why?
Drug Interactions
1
2011
248
0.090
Why?
Physical Examination
2
2010
149
0.090
Why?
Intelligence Tests
2
2021
38
0.090
Why?
Blood Glucose
1
2014
873
0.090
Why?
Abdominal Pain
2
2004
137
0.090
Why?
Sickness Impact Profile
1
2009
27
0.090
Why?
Cost of Illness
2
2012
150
0.090
Why?
Radiography
2
2005
813
0.090
Why?
Up-Regulation
1
2012
715
0.090
Why?
Biomarkers
2
2014
1718
0.090
Why?
Muscle, Smooth
2
2002
354
0.090
Why?
Device Removal
1
2011
161
0.090
Why?
Methotrexate
2
1986
249
0.080
Why?
Tensile Strength
2
2006
79
0.080
Why?
Equipment Failure
2
2006
119
0.080
Why?
Child, Preschool
2
2014
3613
0.080
Why?
Hydroxyzine
1
2008
7
0.080
Why?
Amitriptyline
1
2008
11
0.080
Why?
Multicenter Studies as Topic
1
2009
159
0.080
Why?
Therapeutic Irrigation
1
2008
60
0.080
Why?
Histamine H1 Antagonists
1
2008
40
0.080
Why?
Office Visits
1
2008
44
0.080
Why?
Medical Audit
1
2008
41
0.080
Why?
Muscle Hypotonia
1
1988
45
0.080
Why?
Diseases in Twins
1
2008
65
0.080
Why?
Health Surveys
4
2012
239
0.080
Why?
Child Behavior
2
2021
48
0.080
Why?
Periodicals as Topic
1
2009
168
0.080
Why?
Analgesics
1
2008
119
0.080
Why?
Urethral Neoplasms
1
1987
10
0.080
Why?
Libido
1
2006
8
0.070
Why?
Length of Stay
2
2000
704
0.070
Why?
Preoperative Care
2
2005
397
0.070
Why?
Marriage
1
2006
26
0.070
Why?
Trophoblasts
1
1986
33
0.070
Why?
Elasticity
1
2006
94
0.070
Why?
RNA, Messenger
1
2012
1981
0.070
Why?
Uterine Neoplasms
3
1986
227
0.070
Why?
Equipment Safety
1
2005
31
0.070
Why?
Muscle Strength
1
2005
31
0.070
Why?
Organizations
3
2010
17
0.070
Why?
Forecasting
1
2007
305
0.070
Why?
Family Practice
1
2006
84
0.070
Why?
Cyanates
1
2005
1
0.070
Why?
Vulvitis
1
2005
2
0.070
Why?
Clobetasol
1
2005
3
0.070
Why?
Foreign-Body Reaction
1
2005
11
0.070
Why?
Demography
1
2005
177
0.070
Why?
Nerve Block
1
2005
51
0.060
Why?
Cross-Linking Reagents
1
2005
86
0.060
Why?
Benzofurans
1
2004
8
0.060
Why?
Valsalva Maneuver
1
2004
6
0.060
Why?
Life Tables
1
2004
48
0.060
Why?
Cadaver
2
2004
185
0.060
Why?
Actinomycosis
1
2004
12
0.060
Why?
Central Nervous System
1
2005
151
0.060
Why?
Pyrrolidines
1
2004
58
0.060
Why?
Trophoblastic Neoplasms
1
1984
5
0.060
Why?
Receptor, Cholecystokinin B
1
2004
3
0.060
Why?
Cholecystokinin
1
2004
15
0.060
Why?
Vision Disorders
1
2004
75
0.060
Why?
Genital Diseases, Female
1
2004
24
0.060
Why?
Triplets
1
2003
8
0.060
Why?
Panic Disorder
1
2004
22
0.060
Why?
Pregnancy Complications, Neoplastic
1
1984
28
0.060
Why?
Electromyography
1
2004
183
0.060
Why?
Swine
1
2005
555
0.060
Why?
Twins
1
2003
65
0.060
Why?
Salivation
1
2003
3
0.060
Why?
Northwestern United States
1
2003
6
0.060
Why?
Obesity
1
2010
964
0.060
Why?
Sexual Behavior
1
2006
302
0.060
Why?
Indigo Carmine
1
2002
3
0.060
Why?
Self Care
1
2004
164
0.060
Why?
Coloring Agents
1
2002
64
0.060
Why?
Congresses as Topic
1
2003
116
0.050
Why?
Bioprosthesis
1
2002
36
0.050
Why?
Transducers, Pressure
1
2001
6
0.050
Why?
Methods
4
1989
152
0.050
Why?
Hippurates
1
2021
3
0.050
Why?
Methenamine
1
2021
3
0.050
Why?
Fiber Optic Technology
1
2001
35
0.050
Why?
Practice Guidelines as Topic
1
2008
1037
0.050
Why?
Intraoperative Complications
1
2002
185
0.050
Why?
Adolescent Development
1
2021
18
0.050
Why?
Fasciotomy
1
2000
16
0.050
Why?
Sensitivity and Specificity
3
1996
1992
0.050
Why?
Fasciitis, Necrotizing
1
2000
13
0.050
Why?
Parkinson Disease
1
2002
132
0.050
Why?
Substance-Related Disorders
2
1996
394
0.050
Why?
Disease Models, Animal
1
2007
2231
0.050
Why?
Polymorphism, Genetic
1
2004
819
0.040
Why?
Adolescent Behavior
1
2021
106
0.040
Why?
Time-to-Treatment
1
2021
98
0.040
Why?
Maximum Tolerated Dose
2
2012
270
0.040
Why?
Bone Screws
1
1999
44
0.040
Why?
Nickel
1
2019
13
0.040
Why?
Incontinence Pads
1
1999
4
0.040
Why?
Child Development
1
2021
163
0.040
Why?
Posture
2
1991
125
0.040
Why?
Bisacodyl
1
1978
1
0.040
Why?
Proctitis
1
1978
12
0.040
Why?
Patient Selection
1
2002
686
0.040
Why?
Enema
1
1978
37
0.040
Why?
Sacrum
1
2018
40
0.040
Why?
Suppositories
1
1998
3
0.040
Why?
Administration, Rectal
1
1998
12
0.040
Why?
Behavior Therapy
2
1990
75
0.040
Why?
Bacterial Infections
1
1999
182
0.040
Why?
Phosphates
1
1978
160
0.040
Why?
Neoplasm Recurrence, Local
1
1984
1313
0.040
Why?
Choriocarcinoma
3
1986
7
0.040
Why?
Patient Reported Outcome Measures
1
2018
166
0.040
Why?
Urinalysis
1
1997
33
0.040
Why?
General Practice
1
2016
8
0.040
Why?
Supine Position
1
1996
30
0.040
Why?
Curriculum
1
2001
543
0.040
Why?
Fluocortolone
1
1996
1
0.030
Why?
Retinitis
1
1996
3
0.030
Why?
Urologic Neoplasms
1
1997
77
0.030
Why?
Methylprednisolone
1
1996
66
0.030
Why?
Gastrointestinal Hemorrhage
1
1978
230
0.030
Why?
Referral and Consultation
1
2018
328
0.030
Why?
Uveitis
1
1996
29
0.030
Why?
Stress, Physiological
1
1996
227
0.030
Why?
Ovarian Neoplasms
1
2001
744
0.030
Why?
Statistics, Nonparametric
2
2007
308
0.030
Why?
Kaplan-Meier Estimate
1
2016
861
0.030
Why?
Schizophrenia, Paranoid
1
1993
4
0.030
Why?
Neuropsychological Tests
1
1996
502
0.030
Why?
Glucocorticoids
1
1996
352
0.030
Why?
Adenocarcinoma
1
2001
1169
0.030
Why?
Crime
1
1993
36
0.030
Why?
Body Mass Index
2
2008
770
0.030
Why?
Intestinal Mucosa
1
1978
797
0.030
Why?
Infant
1
2019
3047
0.030
Why?
Schizophrenic Psychology
1
1993
129
0.030
Why?
Caregivers
1
2014
151
0.030
Why?
ROC Curve
1
1995
752
0.030
Why?
Canada
1
2012
204
0.030
Why?
Health Status
1
2014
360
0.030
Why?
Alcoholism
1
1993
172
0.030
Why?
Labor Stage, Second
1
2011
4
0.030
Why?
Electrosurgery
1
2011
9
0.030
Why?
Chorionic Gonadotropin
3
1986
72
0.030
Why?
Cephalometry
1
2011
50
0.030
Why?
Prognosis
2
1990
3680
0.030
Why?
Violence
1
1993
143
0.030
Why?
Baths
1
2011
8
0.020
Why?
Therapeutic Equivalency
1
2011
12
0.020
Why?
Sunscreening Agents
1
2011
7
0.020
Why?
United States Food and Drug Administration
1
2011
127
0.020
Why?
Activities of Daily Living
1
2012
204
0.020
Why?
Kidney
1
1997
1242
0.020
Why?
Adrenergic alpha-Agonists
1
1990
34
0.020
Why?
Tomography, X-Ray Computed
2
1999
2601
0.020
Why?
Videotape Recording
1
1990
47
0.020
Why?
Fetus
1
2011
226
0.020
Why?
Area Under Curve
1
2011
334
0.020
Why?
Clinical Protocols
1
1990
156
0.020
Why?
Massage
1
1989
3
0.020
Why?
Mass Screening
1
2014
619
0.020
Why?
Physical Therapy Modalities
1
1990
84
0.020
Why?
Dilatation
1
1989
48
0.020
Why?
Frail Elderly
1
2010
71
0.020
Why?
Polyuria
1
2009
8
0.020
Why?
Water
1
2011
277
0.020
Why?
Administration, Topical
1
2009
95
0.020
Why?
Regression Analysis
1
2010
596
0.020
Why?
Algorithms
1
1997
1830
0.020
Why?
Consensus
1
2010
336
0.020
Why?
Manometry
1
1987
43
0.020
Why?
Patient Education as Topic
1
1990
351
0.020
Why?
Hydatidiform Mole, Invasive
2
1984
2
0.020
Why?
Single-Blind Method
1
2007
153
0.020
Why?
Pregnancy, Tubal
1
1986
4
0.020
Why?
Cattle
1
2007
376
0.020
Why?
Enuresis
1
1986
4
0.020
Why?
Twin Studies as Topic
1
2006
19
0.020
Why?
Skin Physiological Phenomena
1
2006
27
0.020
Why?
Premenopause
1
2006
54
0.020
Why?
Cross-Over Studies
1
2007
399
0.020
Why?
Pregnancy, Ectopic
1
1986
36
0.020
Why?
Microscopy, Electron
1
1986
503
0.020
Why?
Focus Groups
1
2006
155
0.020
Why?
Lasers
1
1986
106
0.020
Why?
Postmenopause
1
2006
98
0.020
Why?
Diagnostic Imaging
1
2010
469
0.020
Why?
Biomedical Research
1
2010
376
0.020
Why?
Vulva
1
2005
23
0.020
Why?
Anesthetics, Local
1
2005
76
0.020
Why?
Shock, Septic
1
1986
102
0.020
Why?
Cell Division
1
1986
696
0.020
Why?
Linear Models
1
2006
422
0.020
Why?
In Vitro Techniques
1
1986
989
0.020
Why?
Drug Delivery Systems
1
2006
178
0.020
Why?
Genital Neoplasms, Female
1
1986
107
0.020
Why?
Rectus Abdominis
1
2004
37
0.010
Why?
Surgical Instruments
1
2004
57
0.010
Why?
Dermatitis, Contact
1
2003
6
0.010
Why?
Staphylococcal Infections
1
1986
255
0.010
Why?
Headache
1
2003
73
0.010
Why?
Interviews as Topic
1
2004
319
0.010
Why?
Biopsy
1
1986
1163
0.010
Why?
Hydatidiform Mole
1
1982
6
0.010
Why?
Diarrhea
1
2003
182
0.010
Why?
Gene Frequency
1
2004
677
0.010
Why?
Analgesics, Opioid
1
2005
413
0.010
Why?
Electromagnetic Fields
1
2000
26
0.010
Why?
Residence Characteristics
1
2002
197
0.010
Why?
Nervous System Diseases
1
2001
151
0.010
Why?
Suction
1
1999
35
0.010
Why?
Debridement
1
1999
56
0.010
Why?
Genotype
1
2004
1852
0.010
Why?
Genetic Variation
1
2004
1351
0.010
Why?
Treatment Refusal
1
1996
60
0.010
Why?
Bacteria
1
1999
447
0.010
Why?
Depressive Disorder
1
1996
218
0.010
Why?
Anti-Bacterial Agents
1
1999
747
0.010
Why?
Psychiatric Status Rating Scales
1
1996
487
0.010
Why?
Bipolar Disorder
1
1996
377
0.010
Why?
Pregnancy Tests
1
1986
2
0.000
Why?
Uterine Hemorrhage
1
1986
19
0.000
Why?
Hysterosalpingography
1
1986
7
0.000
Why?
Hemoperitoneum
1
1986
4
0.000
Why?
Amenorrhea
1
1986
27
0.000
Why?
Drug Evaluation
1
1986
141
0.000
Why?
Laparoscopy
1
1986
754
0.000
Why?
Infant, Newborn
1
1982
2379
0.000
Why?
Sand's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (518)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_